Danielle Antalffy Analyst Performance

Analyst at UBS Group

Danielle Antalffy is a stock analyst at UBS Group focused in the medical sector, covering 24 publicly traded companies. Over the past year, Danielle Antalffy has issued 19 stock ratings, including buy, hold, and sell recommendations. While full access to Danielle Antalffy's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Danielle Antalffy's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

75 Last 10 Years

Buy Recommendations

72.60% 53 Buy Ratings

Companies Covered

24 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	72.6%	53 ratings
Hold	26.0%	19 ratings
Sell	1.4%	1 ratings

Out of 73 total stock ratings issued by Danielle Antalffy at UBS Group, the majority (72.6%) have been Buy recommendations, followed by 26.0% Hold and 1.4% Sell.

Best & Worst Calls

• Best Call

  0000.0%

  HTWR

  Jan 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  NVRO

  Aug 2021

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	50.0% of companies on NYSE	12 companies
NASDAQ	50.0% of companies on NASDAQ	12 companies

Danielle Antalffy, an analyst at UBS Group, currently covers 24 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 22 companies	91.7%
	Miscellaneous 2 companies	8.3%

Danielle Antalffy of UBS Group specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED PRODUCTS 8 companies	33.3%
MED INSTRUMENTS 8 companies	33.3%
SURGICAL & MEDICAL INSTRUMENTS 3 companies	12.5%
MEDICAL INFO SYS 2 companies	8.3%
Miscellaneous 2 companies	8.3%
LARGE CAP PHARMA 1 company	4.2%

About Danielle Antalffy

Danielle Antalffy currently works at UBS Securities LLC, as Analyst from 2022. Ms. Antalffy also formerly worked at Leerink Partners LLC, as Managing Director from 2008 to 2022, Bear, Stearns & Co., Inc., as Research Analyst from 2006 to 2008, and Janney Montgomery Scott LLC, as Research Associate. Ms. Antalffy received her undergraduate degree in 2002 from the University of Pennsylvania.

Danielle Antalffy's Ratings History at UBS Group

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
MDT Medtronic	8/20/2025	Boost Price Target	$93.29	$95.00	Neutral	$0.00 00.00% ROI
ZBH Zimmer Biomet	8/8/2025	Boost Price Target	$97.67	$96.00	Sell	$0.00 00.00% ROI
TMCI Treace Medical Concepts	8/8/2025	Reiterated Rating	$6.26	$6.50	Neutral	$0.00 00.00% ROI
RXST RxSight	8/8/2025	Lower Price Target	$7.35	$8.00	Neutral	$0.00 00.00% ROI
ENOV Enovis	8/8/2025	Lower Price Target	$28.91	$57.00	Buy	$0.00 00.00% ROI
TNDM Tandem Diabetes Care	8/7/2025	Lower Price Target	$11.27	$17.00	Neutral	$0.00 00.00% ROI
INSP Inspire Medical Systems	8/5/2025	Set Price Target	$79.42	$230.00	Buy	$0.00 00.00% ROI
BAX Baxter International	8/4/2025	Lower Price Target	$22.13	$24.00	Neutral	$0.00 00.00% ROI
DXCM DexCom	7/31/2025	Boost Price Target	$89.06	$106.00	Buy	$0.00 00.00% ROI
GKOS Glaukos	7/31/2025	Boost Price Target	$94.02	$134.00	Buy	$0.00 00.00% ROI
BSX Boston Scientific	7/24/2025	Boost Price Target	$105.63	$135.00	Buy	$0.00 00.00% ROI
ISRG Intuitive Surgical	7/23/2025	Boost Price Target	$501.95	$585.00	Neutral	$0.00 00.00% ROI
JNJ Johnson & Johnson	7/17/2025	Boost Price Target	$163.41	$190.00	Buy	$0.00 00.00% ROI
TMCI Treace Medical Concepts	5/9/2025	Lower Price Target	$6.83	$8.60	Neutral	$0.00 00.00% ROI
ATRC AtriCure	4/30/2025	Lower Price Target	$29.29	$58.00	Buy	$0.00 00.00% ROI
INMD InMode	4/29/2025	Lower Price Target	$14.16	$16.25	Neutral	$0.00 00.00% ROI
MDT Medtronic	2/19/2025	Boost Price Target	$86.05	$95.00	Neutral	$0.00 00.00% ROI
BSX Boston Scientific	2/7/2025	Boost Price Target	$105.15	$130.00	Buy	$0.00 00.00% ROI
ABT Abbott Laboratories	1/23/2025	Boost Price Target	$117.76	$148.00	Buy	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.